News in brief: Key Neurotech phase III trial underway; London dates confirmed for Cannabis Europa; Vitura sets AGM date by Steve Jones September 22, 2026September 24, 2026 Drug development firm Neurotech International (NTI) has dosed the first patient in its pivotal phase III […]
Vitura faces $6m revenue hit as Bupa redirects Doctors on Demand patients by Adam Sheldon September 7, 2026September 8, 2026
‘Race to the bottom’ not for us, says Vitura as firm moves away from ‘cheap and cheerful’ market by Steve Jones August 28, 2026August 28, 2026
Vitura performance ‘sobering’, says CEO amid $4.4 million loss by Steve Jones August 26, 2026August 26, 2026
Vitura’s future success ‘tested’ by market as new CEO calls for business to mature by Adam Sheldon July 29, 2026July 29, 2026
Vitura shakes up leadership structure to cut costs and close the gap with patients by Steve Jones July 22, 2026July 22, 2026
Former Vitura CEO alleges firm sacked him after raising financial concerns by Adam Sheldon June 10, 2026June 11, 2026
Tom Howitt returns to Vitura after early exit of finance chief by Adam Sheldon June 9, 2026June 10, 2026
Ex-Vitura CEO Geoff Cockerill sues firm over termination by Adam Sheldon and Steve Jones May 20, 2026May 22, 2026
